152 related articles for article (PubMed ID: 36556501)
1. Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation-Family Case Report and Review of the Literature.
Marcu AS; Vătăşescu R; Onciul S; Rădoi V; Jurcuţ R
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556501
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy.
Tang L; Li X; Zhou N; Jiang Y; Pan C; Shu X
Cardiovasc Ultrasound; 2022 May; 20(1):14. PubMed ID: 35509080
[TBL] [Abstract][Full Text] [Related]
3. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.
Thevenon J; Laurent G; Ader F; Laforêt P; Klug D; Duva Pentiah A; Gouya L; Maurage CA; Kacet S; Eicher JC; Albuisson J; Desnos M; Bieth E; Duboc D; Martin L; Réant P; Picard F; Bonithon-Kopp C; Gautier E; Binquet C; Thauvin-Robinet C; Faivre L; Bouvagnet P; Charron P; Richard P
Europace; 2017 Apr; 19(4):651-659. PubMed ID: 28431061
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
6. Patient with a PRKAG2 mutation who developed Immunoglobulin A nephropathy: a case report.
Giudici MC; Ahmad F; Holanda DG
Eur Heart J Case Rep; 2019 Jun; 3(2):. PubMed ID: 31449595
[TBL] [Abstract][Full Text] [Related]
7. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
[TBL] [Abstract][Full Text] [Related]
8. Cardiac manifestations of PRKAG2 mutation.
Banankhah P; Fishbein GA; Dota A; Ardehali R
BMC Med Genet; 2018 Jan; 19(1):1. PubMed ID: 29298659
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
Oliveira SM; Ehtisham J; Redwood CS; Ostman-Smith I; Blair EM; Watkins H
J Mol Cell Cardiol; 2003 Oct; 35(10):1251-5. PubMed ID: 14519435
[TBL] [Abstract][Full Text] [Related]
10. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic expression and clinical outcomes in a South Asian PRKAG2 cardiomyopathy cohort.
Ahamed H; Balegadde AV; Menon S; Menon R; Ramachandran A; Mathew N; Natarajan KU; Nair IR; Kannan R; Shankar M; Mathew OK; Nguyen TT; Gupta R; Stawiski EW; Ramprasad VL; Seshagiri S; Phalke S
Sci Rep; 2020 Nov; 10(1):20610. PubMed ID: 33244021
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
[TBL] [Abstract][Full Text] [Related]
13. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
14. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
15. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
[TBL] [Abstract][Full Text] [Related]
16. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
[TBL] [Abstract][Full Text] [Related]
17. Case report: Genomic screening for inherited cardiac conditions in Ecuadorian mestizo relatives: Improving familial diagnose.
Cadena-Ullauri S; Guevara-Ramirez P; Ruiz-Pozo V; Tamayo-Trujillo R; Paz-Cruz E; Sánchez Insuasty T; Doménech N; Ibarra-Rodríguez AA; Zambrano AK
Front Cardiovasc Med; 2022; 9():1037370. PubMed ID: 36426223
[TBL] [Abstract][Full Text] [Related]
18. A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation.
Yang KQ; Lu CX; Zhang Y; Yang YK; Li JC; Lan T; Meng X; Fan P; Tian T; Wang LP; Liu YX; Zhang X; Zhou XL
Sci Rep; 2017 May; 7(1):2407. PubMed ID: 28546535
[TBL] [Abstract][Full Text] [Related]
19. Novel PRKAG2 variant presenting as liver cirrhosis: report of a family with 2 cases and review of literature.
Beyzaei Z; Ezgu F; Geramizadeh B; Alborzi A; Shojazadeh A
BMC Med Genomics; 2021 Jan; 14(1):33. PubMed ID: 33509202
[TBL] [Abstract][Full Text] [Related]
20. PRKAG2 mutations presenting in infancy.
Torok RD; Austin SL; Phornphutkul C; Rotondo KM; Bali D; Tatum GH; Wechsler SB; Buckley AF; Kishnani PS
J Inherit Metab Dis; 2017 Nov; 40(6):823-830. PubMed ID: 28801758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
